摘要 |
A pharmacological composition comprises an antiviral agent and a chelator in a quantity sufficient to reduce a serum concentration of a bivalent metal in an amount of at least 25%, wherein preferred antiviral agents include protease inhibitors, reverse transcriptase inhibitors, and/or an antibody, and wherein preferred chelators chelate at least one of Ca2+ and Mg2+.
|